Aesthetic Medical International Holdings Group (PAIYY) AI Stock Analysis

• Market Cap: $10.22M
• Dividend Yield: N/A
• Average Volume (3M): 610.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.41
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 1,286
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Equipment & Services
• EPS (TTM): N/A
• Shares Outstanding: 48,687,584
• 10 Day Avg. Volume: 408
• 30 Day Avg. Volume: 610
• PEG Ratio: 0.04
• Price to Book (P/B): 1.17
• Price to Sales (P/S): 0.05
• P/FCF Ratio: 0.73
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $0.50
• Price Target Upside: 138.10% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 53 Neutral
• Price Target: $0.00 ▼(-100.00% Downside)

The overall stock score is driven primarily by financial performance and technical analysis. While the company shows revenue growth and improved cash flow, profitability and balance sheet leverage remain concerns. Technical indicators suggest positive momentum, but valuation metrics are lacking, adding uncertainty to the stock's attractiveness.

Aesthetic Medical International Holdings Group Business Overview & Revenue Model

Company Description

Aesthetic Medical International Holdings Group (PAIYY) is a leading provider of aesthetic medical services in China. The company operates through a network of treatment centers offering a range of services, including surgical and non-surgical aesthetic procedures, dermatology, and other related medical services. PAIYY is committed to improving patient experience and outcomes through advanced medical technologies and a professional team of healthcare providers.

How the Company Makes Money

Aesthetic Medical International Holdings Group generates revenue primarily through its aesthetic medical services, which include both surgical and non-surgical procedures. These services are offered across various treatment centers strategically located to capture a broad customer base. The company also benefits from selling skincare and beauty products as part of their service offerings. Additionally, PAIYY may engage in partnerships with medical technology firms to enhance their service delivery, potentially creating additional revenue streams through collaborative service enhancements or innovative product offerings.

Aesthetic Medical International Holdings Group Financial Statement Overview

Summary

Aesthetic Medical International Holdings Group is making strides towards improvement, with notable revenue growth and better cash flow management. Nevertheless, profitability remains elusive, and the balance sheet's leverage presents risks. Continued focus on reducing debt and enhancing profitability is essential for future stability.

Income Statement

The company has shown improvement in reducing its operating losses, with EBIT rising from -48.81 million to -4.04 million. Revenue growth is evident with a 10.7% increase from the previous year. However, the net profit margin remains negative, indicating ongoing challenges in achieving profitability. Continued focus on cost management is needed.

Balance Sheet

The company's financial stability is concerning, with a high debt-to-equity ratio due to significant liabilities overshadowing the small equity base. The equity ratio is low at 6.3%, indicating heavy reliance on debt financing. However, there have been improvements in stockholders' equity and asset management, which is a positive sign.

Cash Flow

The cash flow situation has improved, with a positive free cash flow growing significantly from the previous year. The operating cash flow is healthy and exceeds net income, indicating strong cash generation capabilities despite net losses. Continued improvement in free cash flow sustainability is crucial.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	755.67M	682.59M	670.09M	645.59M	901.57M
Gross Profit	337.79M	322.05M	355.59M	269.50M	544.78M
EBITDA	73.33M	25.31M	-11.05M	-554.95M	-123.90M
Net Income	-19.95M	-37.43M	-76.25M	-586.62M	-235.48M
Balance Sheet
Total Assets	486.22M	560.66M	546.37M	576.94M	1.04B
Cash, Cash Equivalents and Short-Term Investments	42.84M	62.34M	12.16M	39.29M	44.38M
Total Debt	179.30M	244.55M	393.10M	405.91M	460.79M
Total Liabilities	476.88M	527.03M	672.25M	763.36M	612.35M
Stockholders Equity	30.46M	48.89M	-113.66M	-156.67M	390.90M
Cash Flow
Free Cash Flow	48.88M	18.83M	-76.80M	17.65M	-46.01M
Operating Cash Flow	79.67M	74.29M	-75.13M	51.09M	-843.00K
Investing Cash Flow	-30.32M	-52.25M	3.11M	-11.53M	-127.37M
Financing Cash Flow	-68.55M	29.06M	45.55M	-45.23M	17.70M

Aesthetic Medical International Holdings Group Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.21
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PAIYY, the sentiment is Positive. The current price of 0.21 is above the 20-day moving average (MA) of 0.20, above the 50-day MA of 0.18, and below the 200-day MA of 0.22, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 53.08 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PAIYY.

Aesthetic Medical International Holdings Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PAIYY	53 Neutral	$10.22M	―	-76.57%	―	―	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
CCM	44 Neutral	$25.85M	―	14.03%	―	-22.38%	56.66%
PSTV	43 Neutral	$69.22M	―	249.03%	―	-3.49%	27.88%
SNSE	40 Underperform	$14.20M	―	-67.47%	―	―	9.63%
GOVX	34 Underperform	$17.82M	―	-9690.24%	―	1943.07%	80.97%